Study title: Klifo/MST/160891 - Post marketing surveillance, Drug monitoring, 06-Jul-1998. Beurteilung der Lebensqualität bei Patienten mit Krebsschmerzen unter Berücksichtigung ihrer Schmerztherapie gemäß Stufenplan WHO. (MST Mundipharma for treatment of cancer pain in practices) (Germany)
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Anesthesia and Analgesia | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: MORPHINE | |||||
ATC code: N02A A03 | |||||
Document link: | |||||
Document date: | |||||
Study number: | |||||
EudraCT number: | |||||
Scope of study: CLINICAL | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |